PepGen Ltd (PEPG)

PepGen Ltd (PEPG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $166M; returns 1 day -6.7%, 1 week -3.1%, 1 year -44.0%.

PepGen Ltd. is a clinical-stage biotechnology company focused on developing oligonucleotide therapies for severe neuromuscular and neurological diseases. Their Enhanced Delivery Oligonucleotide (EDO) platform aims to improve the uptake and activity of conjugated oligonucleotide therapeutics.

Groups PEPG belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Duchenne Muscular Dystrophy
• Rare Diseases
• Neurological Disorders
• Life Sciences
• Neuroscience
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biopharma
• R&D

PEPG financial model: income statement, cash flow and balance sheet